ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 920,95
0,09%
DAX
18 557,27
-0,48%
Brent Oil
79,435
-0,56%
Bitcoin
69 042,83
-2,43%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. OmniAb Inc (OABI)

  7. OmniAb Inc (OABI) Actualités

OABI

OmniAb (OABI)

OmniAb Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OABI
DateHeureSourceTitreSymboleSociété
04/06/202413h20Business WireOmniAbが重鎖単一ドメイン抗体ニワトリプラットフォームに関する学術論文を米国免疫学会雑誌に発表NASDAQ:OABIOmniAb Inc
03/06/202422h05Business WireOmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of ImmunologyNASDAQ:OABIOmniAb Inc
20/05/202414h05Business WireOmniAb to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OABIOmniAb Inc
15/05/202422h05Business WireOmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston SummitNASDAQ:OABIOmniAb Inc
09/05/202422h05Business WireOmniAb Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
01/05/202414h00Business WireOmniAb to Participate in Five Investor Conferences in MayNASDAQ:OABIOmniAb Inc
22/04/202414h00Business WireOmniAb to Report First Quarter 2024 Financial Results on May 9NASDAQ:OABIOmniAb Inc
20/03/202421h05Business WireOmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
26/02/202414h00Business WireOmniAb to Report Fourth Quarter 2023 Financial Results on March 20NASDAQ:OABIOmniAb Inc
20/02/202414h00Business WireOmniAb to Participate in Two Investor Conferences in MarchNASDAQ:OABIOmniAb Inc
14/12/202322h30Business WireOmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics ConferenceNASDAQ:OABIOmniAb Inc
09/11/202323h55Business WireOmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
09/11/202314h00Business WireOmniAb Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
02/11/202313h00Business WireOmniAb to Participate in Two Investor Conferences in NovemberNASDAQ:OABIOmniAb Inc
01/11/202314h00Business WireOmniAb Appoints Steve Love to its Board of DirectorsNASDAQ:OABIOmniAb Inc
31/10/202321h28Business WireOmniAb Announces Agenda for its Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
12/10/202314h00Business WireOmniAb to Hold Research & Technology Virtual Event on November 9NASDAQ:OABIOmniAb Inc
05/09/202314h00Business WireOmniAb to Participate in Two Investor Conferences in SeptemberNASDAQ:OABIOmniAb Inc
10/08/202322h05Business WireOmniAb Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
07/08/202322h05Business WireOmniAb Announces the Passing of Director Sunil PatelNASDAQ:OABIOmniAb Inc
31/07/202314h00Business WireOmniAb to Report Second Quarter 2023 Financial Results on August 10NASDAQ:OABIOmniAb Inc
17/05/202322h05Business WireOmniAb Launches OmniDeep™ at the PEGS Boston Conference and ExpoNASDAQ:OABIOmniAb Inc
11/05/202313h00Business WireOmniAb Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
01/05/202314h00Business WireOmniAb to Report First Quarter 2023 Financial Results on May 11NASDAQ:OABIOmniAb Inc
25/04/202314h00Business WireOmniAb to Participate in Upcoming Investor Conferences in MayNASDAQ:OABIOmniAb Inc
30/03/202322h05Business WireOmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
09/03/202314h00Business WireOmniAb to Report Fourth Quarter 2022 Financial Results on March 30NASDAQ:OABIOmniAb Inc
07/02/202314h00Business WireOmniAb to Participate in Three Upcoming Investor ConferencesNASDAQ:OABIOmniAb Inc
01/12/202214h47GlobeNewswire Inc.Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and UndruggableNASDAQ:OABIOmniAb Inc
15/11/202213h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OABIOmniAb Inc
 Showing the most relevant articles for your search:NASDAQ:OABI

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
EU
BNP
BNP Paribas
EU
PX1
CAC 40
NYSE
KO
Coca Cola
EU
CAP
Capgemini
NASDAQ
AAPL
Apple
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés